Categories: News

Angelalign Technologies Remains Confident in Light of its Competitor’s New Complaint and Diversion Tactic

SAN CLEMENTE, Calif., Sept. 24, 2025 /PRNewswire/ — Angelalign Technology Inc. (6699.HK) (“Angel”) remains confident in its position in light of the fact that industry behemoth Align Technology Inc. (ALGN) has filed another meritless case against Angel, this time with the U.S. International Trade Commission. This is the latest in a barrage of lawsuits launched by Align.

Angel promises an effective defense and is confident that it will prevail. The company has innovated and operated for over 20 years with a strong reputation and track record of respecting intellectual property. Angel serves doctors and patients in 60 countries and regularly receives industry-leading satisfaction ratings.

“Since the last series of lawsuits, many orthodontic industry executives and orthodontists have reached out to us to express support and appreciation for the benefits our products provide to their patients. They hope Angel can continue to bring a breath of fresh air to an industry burdened by anti-trust lawsuits and monopolistic allegations. We were taken aback by this outpouring of support, and by the unexpected acceleration in our business in North America,” said Angel’s Chief Commercial Officer and SVP, Rich Hirschland.

Angel has proudly led the clear-aligner field in innovation for many years while also recognizing Align’s founding role in creating the industry years ago. Some examples of Angel’s cutting-edge products are:

  • The award-winning angelButton™ and the angelHook™, which allow orthodontists to manage forces effectively when using elastics.
  • The A6 mandibular advancement system, which implements the twin-block orthodontic concept for doctors to move the mandible.
  • AngelKid, a leading system to treat mixed dentition for young patients.
  • Intelligent Root System, which allows orthodontists to use 3D imaging for treatment planning.

Angel is honored that leading competitors are launching mandibular advancement systems with many design elements like the Angel solution, which celebrated its 10-year anniversary.

“Align’s diversions will not distract us from our priorities,” said Jason Tabb, Angel’s General Manager and VP of North America. “Our priorities are listening to and serving our customers and treating our employees with respect.” See video about Angel’s culture here.

About Angelalign Technology Inc.
Founded in 2003 and celebrating 1.5 million smiles, Angel provides digital technology-driven clear aligner products and services to meet the needs of dental professionals and patients worldwide.

The Company’s innovative products and technical services have established it as a prominent player in the orthodontics industry. In 2021, Angelalign Technology was listed on the Hong Kong Stock Exchange with a current market capitalization of around US$1bn. Learn more at angelaligner.com.

For more information, contact: Sue Kolb, Head of Marketing, Sue.Kolb@angelaligner.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/angelalign-technologies-remains-confident-in-light-of-its-competitors-new-complaint-and-diversion-tactic-302566571.html

SOURCE Angelalign Technology Inc.

Staff

Recent Posts

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

26 minutes ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

3 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

3 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

3 hours ago

A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…

6 hours ago

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

12 hours ago